- Home
- CLDT vs BNTC Comparison
CLDT vs BNTC Comparison
Compare CLDT & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDT
- BNTC
- Stock Information
- Founded
- CLDT 2009
- BNTC 1995
- Country
- CLDT United States
- BNTC United States
- Employees
- CLDT N/A
- BNTC N/A
- Industry
- CLDT Real Estate Investment Trusts
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- CLDT Real Estate
- BNTC Health Care
- Exchange
- CLDT Nasdaq
- BNTC Nasdaq
- Market Cap
- CLDT 374.7M
- BNTC 335.5M
- IPO Year
- CLDT 2010
- BNTC N/A
- Fundamental
- Price
- CLDT $7.61
- BNTC $13.24
- Analyst Decision
- CLDT Strong Buy
- BNTC Strong Buy
- Analyst Count
- CLDT 2
- BNTC 5
- Target Price
- CLDT $10.75
- BNTC $26.00
- AVG Volume (30 Days)
- CLDT 264.3K
- BNTC 40.8K
- Earning Date
- CLDT 08-06-2025
- BNTC 09-25-2025
- Dividend Yield
- CLDT 4.72%
- BNTC N/A
- EPS Growth
- CLDT N/A
- BNTC N/A
- EPS
- CLDT 0.03
- BNTC N/A
- Revenue
- CLDT $310,140,000.00
- BNTC N/A
- Revenue This Year
- CLDT N/A
- BNTC N/A
- Revenue Next Year
- CLDT $0.45
- BNTC N/A
- P/E Ratio
- CLDT $277.86
- BNTC N/A
- Revenue Growth
- CLDT N/A
- BNTC N/A
- 52 Week Low
- CLDT $5.83
- BNTC $8.06
- 52 Week High
- CLDT $10.00
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- CLDT 63.27
- BNTC 59.72
- Support Level
- CLDT $7.57
- BNTC $12.57
- Resistance Level
- CLDT $7.82
- BNTC $13.33
- Average True Range (ATR)
- CLDT 0.16
- BNTC 0.60
- MACD
- CLDT 0.06
- BNTC 0.10
- Stochastic Oscillator
- CLDT 76.92
- BNTC 95.59
About CLDT Chatham Lodging Trust (REIT) of Beneficial Interest
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.